ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: These findings further emphasize that in CML patients, BCR-ABL negative hematopoiesis is sustained by non-neoplastic HSPCs and argues against a substantial mean TL deficit in the normal, Ph− hematopoietic stem cell compartment.